ZA200502982B - Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments. - Google Patents
Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments. Download PDFInfo
- Publication number
- ZA200502982B ZA200502982B ZA200502982A ZA200502982A ZA200502982B ZA 200502982 B ZA200502982 B ZA 200502982B ZA 200502982 A ZA200502982 A ZA 200502982A ZA 200502982 A ZA200502982 A ZA 200502982A ZA 200502982 B ZA200502982 B ZA 200502982B
- Authority
- ZA
- South Africa
- Prior art keywords
- arousal
- patient
- sleep
- onset
- treatment
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title claims description 72
- 238000000034 method Methods 0.000 title claims description 61
- 230000001225 therapeutic effect Effects 0.000 title claims description 38
- 238000012544 monitoring process Methods 0.000 title claims description 33
- 230000003860 sleep quality Effects 0.000 title claims description 11
- 230000037007 arousal Effects 0.000 claims description 153
- 230000007958 sleep Effects 0.000 claims description 72
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 55
- 239000007789 gas Substances 0.000 claims description 45
- 230000000241 respiratory effect Effects 0.000 claims description 36
- 206010021079 Hypopnoea Diseases 0.000 claims description 33
- 230000008859 change Effects 0.000 claims description 31
- 208000008784 apnea Diseases 0.000 claims description 18
- 230000036772 blood pressure Effects 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 208000003417 Central Sleep Apnea Diseases 0.000 claims description 11
- 208000035475 disorder Diseases 0.000 claims description 10
- 230000002739 subcortical effect Effects 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 230000001054 cortical effect Effects 0.000 claims description 9
- 208000001797 obstructive sleep apnea Diseases 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 230000010355 oscillation Effects 0.000 claims description 7
- 238000012360 testing method Methods 0.000 claims description 7
- 238000012377 drug delivery Methods 0.000 claims description 6
- 230000000414 obstructive effect Effects 0.000 claims description 6
- 201000002859 sleep apnea Diseases 0.000 claims description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 4
- 230000035945 sensitivity Effects 0.000 claims description 4
- 230000000747 cardiac effect Effects 0.000 claims description 3
- 230000001276 controlling effect Effects 0.000 claims description 3
- 230000000737 periodic effect Effects 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 239000001569 carbon dioxide Substances 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 230000035790 physiological processes and functions Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 description 29
- 238000012545 processing Methods 0.000 description 22
- 238000004458 analytical method Methods 0.000 description 20
- 208000010340 Sleep Deprivation Diseases 0.000 description 18
- 206010041235 Snoring Diseases 0.000 description 16
- 238000009499 grossing Methods 0.000 description 15
- 230000003434 inspiratory effect Effects 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000009467 reduction Effects 0.000 description 6
- 208000019116 sleep disease Diseases 0.000 description 6
- 206010041349 Somnolence Diseases 0.000 description 5
- 230000006978 adaptation Effects 0.000 description 5
- 230000003044 adaptive effect Effects 0.000 description 5
- 238000002106 pulse oximetry Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 230000003416 augmentation Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 208000037656 Respiratory Sounds Diseases 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 208000000884 Airway Obstruction Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 101000864837 Homo sapiens SIN3-HDAC complex-associated factor Proteins 0.000 description 2
- 101000834991 Homo sapiens Transitional endoplasmic reticulum ATPase Proteins 0.000 description 2
- 241001255854 Teras Species 0.000 description 2
- 102100026145 Transitional endoplasmic reticulum ATPase Human genes 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000000205 computational method Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008667 sleep stage Effects 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 206010021133 Hypoventilation Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 206010048232 Yawning Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003931 cognitive performance Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000004129 prosencephalon Anatomy 0.000 description 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000246 remedial effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 208000021070 secondary pulmonary alveolar proteinosis Diseases 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000008665 sleep physiology Effects 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41744502P | 2002-10-09 | 2002-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200502982B true ZA200502982B (en) | 2006-02-22 |
Family
ID=35719179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200502982A ZA200502982B (en) | 2002-10-09 | 2005-04-13 | Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments. |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1713850B (zh) |
| UA (1) | UA90651C2 (zh) |
| ZA (1) | ZA200502982B (zh) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101850855B1 (ko) * | 2008-09-24 | 2018-04-20 | 레스메드 센서 테크놀로지스 리미티드 | 평가 및 조정을 위한 삶의 질 변수의 비접촉 및 최소접촉 모니터링 |
| WO2011007346A1 (en) * | 2009-06-09 | 2011-01-20 | Respinova Ltd. | Device and methods for applying therapeutic protocols to organs of the cardiopulmonary system |
| NZ735906A (en) | 2009-07-16 | 2019-06-28 | ResMed Pty Ltd | Detection of sleep condition |
| US9272105B2 (en) * | 2010-07-09 | 2016-03-01 | New York University | System and method for diagnosis and treatment of obstructive sleep apnea |
| US10857319B2 (en) | 2011-01-14 | 2020-12-08 | Koninklijke Philips N.V. | Measuring continuity of therapy associated with a respiratory treatment device |
| DE102012003509B4 (de) * | 2012-02-22 | 2020-06-10 | Drägerwerk AG & Co. KGaA | Beatmungssystem |
| EP3639733B1 (en) * | 2012-05-30 | 2022-10-26 | ResMed Sensor Technologies Limited | Apparatus for monitoring cardio-pulmonary health |
| BR112015025073B1 (pt) * | 2013-04-03 | 2021-12-28 | Koninklijke Philips N.V. | Sistema de ventilação |
| US10117616B2 (en) * | 2013-11-22 | 2018-11-06 | Koninklijke Philips N.V. | Apnea safety control |
| CN103637798B (zh) * | 2013-12-17 | 2016-03-09 | 山东大学齐鲁医院 | 一种麻醉深度监测装置 |
| FR3019468B1 (fr) * | 2014-04-02 | 2024-07-12 | Fisher & Paykel Healthcare Ltd | Apport de ventilation en pression positive variable en fonction de troubles respiratoires et de l'etat eveille |
| CA2968645C (en) * | 2015-01-06 | 2023-04-04 | David Burton | Mobile wearable monitoring systems |
| EP3253282A4 (en) * | 2015-02-05 | 2018-09-26 | Mc10, Inc. | Method and system for interacting with an environment |
| CN104689444B (zh) * | 2015-03-26 | 2018-08-24 | 北京怡和嘉业医疗科技股份有限公司 | 正压通气治疗机的压力调整方法及系统 |
| US20190175026A1 (en) * | 2015-11-11 | 2019-06-13 | Inspire Medical Systems, Inc. | Cardiac and sleep monitoring |
| EP3468463B1 (en) * | 2016-06-08 | 2024-07-17 | Itamar Medical Ltd. | Method and apparatus for non-invasive detection of physiological and patho-physiological sleep conditions |
| CA3033216A1 (en) * | 2016-07-13 | 2018-01-18 | Aerofit.Dk Aps | Respiratory device and system for exercising and analysing respiration of a subject |
| CN106039510B (zh) * | 2016-07-29 | 2018-12-25 | 湖南明康中锦医疗科技发展有限公司 | 呼吸机安全控制的方法、呼吸机及云平台 |
| US10636524B2 (en) * | 2016-08-26 | 2020-04-28 | TCL Research America Inc. | Method and system for optimized wake-up strategy via sleeping stage prediction with recurrent neural networks |
| JP6891038B2 (ja) * | 2017-05-15 | 2021-06-18 | オムロン株式会社 | ウエアラブル装置およびプログラム |
| CN107198805A (zh) * | 2017-07-17 | 2017-09-26 | 太仓秦风广告传媒有限公司 | 一种基于自然呼吸的智能雾化治疗设备 |
| TWI728839B (zh) * | 2020-06-12 | 2021-05-21 | 臺北醫學大學 | 居家睡眠監測器、居家睡眠監測系統以及居家睡眠監測及睡眠呼吸事件分類方法 |
| CN113269318B (zh) * | 2021-06-04 | 2023-06-30 | 安谋科技（中国）有限公司 | 电子设备及其神经网络模型运行方法、存储介质 |
| CN114343373B (zh) * | 2022-01-05 | 2024-06-21 | 浙江想能睡眠科技股份有限公司 | 一种智能调节床垫的方法、系统和存储介质 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5522862A (en) * | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
| AUPN627395A0 (en) * | 1995-10-31 | 1995-11-23 | Compumedics Sleep Pty Ltd | Integrated diagnostic and therapeutic device for gas delivery to patient |
| CN1154521C (zh) * | 1997-05-07 | 2004-06-23 | 计算机医药导眠有限公司 | 用于控制对病人的气体供给的设备 |
| EP1121951A1 (de) * | 2000-02-01 | 2001-08-08 | Uvo M. Prof. Hölscher Ph. D. | Regelkreis - System zur Therapie eines Patienten |
| ATE412366T1 (de) * | 2000-12-29 | 2008-11-15 | Ares Medical Inc | Risikobewertung von schlafapnoe |
-
2003
- 2003-09-10 UA UAA200503278A patent/UA90651C2/uk unknown
- 2003-10-09 CN CN200380104013.3A patent/CN1713850B/zh not_active Expired - Fee Related
-
2005
- 2005-04-13 ZA ZA200502982A patent/ZA200502982B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1713850A (zh) | 2005-12-28 |
| UA90651C2 (uk) | 2010-05-25 |
| CN1713850B (zh) | 2012-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8069852B2 (en) | Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments | |
| CA2501607C (en) | Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments | |
| ZA200502982B (en) | Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments. | |
| US10856802B2 (en) | Methods and apparatus for heart failure treatment | |
| EP1750581B1 (en) | Multilevel ventilator | |
| JP7393405B2 (ja) | 睡眠呼吸障害のスクリーニング、診断および監視のためのシステムおよび方法 | |
| US20030139691A1 (en) | Analysis of sleep apnea | |
| US20090107501A1 (en) | System and method of monitoring respiratory airflow and oxygen concentration | |
| AU2006297468A1 (en) | System and method for diagnosis and treatment of a breathing pattern of a patient | |
| Piccin | Monitoring Positive Pressure Therapy in Sleep-Related Breathing Disorders |